Representative image
Representative image

Fighting Covid: Govt mulling to discontinue Azithromycin on critical patients

ANI | Updated: Jun 12, 2020 17:26 IST


New Delhi [India], June 12 (ANI): The Ministry of Health and Family Welfare is likely to withdraw the use of Azithromycin, which was being administered to severely ill COVID-19 patients in the intensive care units (ICUs), from the combination of Azithromycin and Hydroxychloroquine (HCQ).
According to a government official, the use of Azithromycin was not "much beneficial" on coronavirus patients.
However, the antiviral drug HCQ will be used both on moderate and severe COVID-19 patients.
The Union Health Ministry is likely to amend the existing COVID-19 clinical management guidelines issued by the central government. (ANI)

Loading...
iocl
iocl